we have prospectively evaluated the clinical and immunological features of serum sickness in 35 patients treated for bone marrow failure with anti-thymocyte globulin ( atg 15 mg/kg/day ) and methylprednisolone ( 1 to 1.5 mg/kg/day ) .
C0036830
serum
C0025815
methylprednisolone